New combo therapy aims to treat skin cancers without scarring
Disease control
Recruiting now
This early-phase study tests a combination of blue-light photodynamic therapy (a light treatment that kills cancer cells) and the drug sonidegib for people with multiple basal cell carcinomas. The goal is to see if this approach can effectively treat the cancers while avoiding th…
Phase: PHASE1 • Sponsor: Nathalie Zeitouni • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC